Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Accumulated Expenses (2024 - 2025)

Carlsmed (CARL) has disclosed Accumulated Expenses for 2 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses changed N/A year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $2.7 million, changed N/A over the prior year.
  • Accumulated Expenses was $1.6 million for Q3 2025 at Carlsmed, roughly flat from $1.6 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.7 million in Q4 2024 and bottomed at $1.6 million in Q3 2025.